Zai Lab Limited is soliciting shareholder votes at its 2026 Annual General Meeting to be held on June 17, 2026, seeking re-election of nine directors, approval of KPMG LLP/KPMG as auditors for the year ending December 31, 2026, and shareholder mandates to issue and repurchase up to 10% of issued ordinary shares.
The record date for voting is April 16, 2026. The proxy materials reference 1,134,128,030 issued ordinary shares as of April 10, 2026, implying a 10% cap equal to 113,412,803 shares for each proposed mandate.
Zai Lab Ltd officer Joshua L. Smiley reported an automatic tax-related sale of company stock. On April 6, 2026, he sold 3,017 American Depositary Shares (ADSs) at $20.448 per ADS to cover taxes due upon vesting of Restricted Share Units. Each ADS represents ten Ordinary Shares of Zai Lab. After this tax-cover transaction, Smiley directly held 117,602 ADSs, indicating he retained a substantial equity position in the company.
Zai Lab Ltd Chief Legal Officer Edmondson Frazor Titus III reported an automatic sale of 1,224 American Depositary Shares (ADSs) of Zai Lab Ltd to cover taxes upon vesting of Restricted Share Units. The ADSs were sold at an average price of $20.448 per ADS on April 6, 2026.
Each ADS represents ten Ordinary Shares of Zai Lab Ltd. Following this tax-related sale, Edmondson Frazor Titus III directly holds 23,366 ADSs. The transaction reflects a routine disposition tied to equity compensation rather than a discretionary open-market trade.
Zai Lab Ltd Chairperson and CEO Ying Du reported an open-market sale of 2,653 American Depositary Shares (ADSs) of the company at a price of $20.448 per ADS. A filing footnote explains these ADSs were sold automatically to cover taxes upon vesting of Restricted Share Units.
After this tax-related sale, Ying Du directly holds 1,122,626 ADSs. Each ADS represents ten ordinary shares of Zai Lab, and the ADSs and ordinary shares are fully fungible.
Zai Lab Ltd Chief Financial Officer Yajing Chen reported an open-market sale of 853 American Depositary Shares (ADSs) of Zai Lab on April 6, 2026 at an average price of $20.448 per ADS. Each ADS represents ten ordinary shares, and the company states its ADSs and ordinary shares are fully fungible, though this report is presented in ADS terms.
According to the disclosure, these ADSs were sold automatically to cover taxes triggered by the vesting of Restricted Share Units, indicating a tax-withholding related transaction rather than a discretionary portfolio decision. After this sale, Chen directly holds 31,705 ADSs, showing that the transaction affects only a small portion of her reported direct holdings.
Zai Lab Ltd officer Rafael Amado reported an open-market sale of 2,739 American Depositary Shares (ADSs) at $20.448 per ADS. Each ADS represents ten ordinary shares. After the transaction, he directly holds 57,022 ADSs.
According to the filing, these ADSs were sold automatically to cover taxes due upon the vesting of Restricted Share Units, indicating the sale was driven by tax obligations rather than a discretionary portfolio decision.
Zai Lab Limited filed a Schedule 13G reporting beneficial ownership of 57,435,330 ordinary shares, held via 5,743,533 ADSs (each ADS = ten ordinary shares). The stake represents 5.2% of shares outstanding based on 1,106,407,390 ordinary shares outstanding as of Feb 20, 2026. The holdings are reported by RA Capital Management, L.P., RA Capital Healthcare Fund, L.P., and related individuals; voting and dispositive powers are described as shared holdings and certain disclaimers of beneficial ownership appear in the filing.
ZLAB reported proposed sales of American Depositary Shares via a Form 144 notice indicating insider dispositions. The filing lists a restricted stock vesting issuance of 3,017 ADS on 04/02/2026 and two reported past sales by Joshua L. Smiley totaling 11,580 ADS across 03/13/2026 and 04/02/2026.
ZLAB affiliate filed a Form 144 reporting proposed and recent sales of American Depositary Shares. The filing lists restricted stock vesting on 04/02/2026 and multiple dispositions by Ying Du in March–April 2026, including several 50,000-share sales and smaller transactions.
ZLAB reported a Form 144 notice listing proposed or recent sales of American Depositary Shares by Frazor T. Edmondson. The filing lists three transactions: 15,569 shares for $296,745.14 on 03/05/2026; 1,281 shares for $23,862.72 on 03/13/2026; and 4,194 shares for $85,516.08 on 04/02/2026
The filing also notes restricted stock vesting of American Depositary Shares on 04/02/2026 reported as compensation. The notice identifies Fidelity Brokerage Services LLC and lists NASDAQ as the exchange.